| Drug Type Proteolysis-targeting chimeras (PROTAC) | 
| Synonyms HBL-5 | 
| Target | 
| Action degraders | 
| Mechanism BRD4 degraders(Bromodomain-containing protein 4 degraders), PLK1 degraders(Polo like kinase 1 degraders), Epigenetic drug | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Molecular FormulaC45H57N9O11 | 
| InChIKeyGLNZQWXKBMEKNA-BONSOQDYSA-N | 
| CAS Registry2890766-69-3 | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Acute Myeloid Leukemia | Preclinical | China  | - | 





